The Changing Landscape in EGIDs Beyond the Esophagus

Sunday, May 23, 2021

7:15 pm – 8:30 pm  EDT



Eosinophilic gastrointestinal diseases (EGIDs) are serious, chronic, inflammatory digestive disorders characterized by excessive infiltration of eosinophils into gastrointestinal (GI) tissues. Lengthy diagnostic delays are common and often result in disease progression and missed treatment opportunities. In this virtual, live CME event, 3 experts will discuss the pathophysiology, diagnosis, and treatment of EGIDs below the esophagus. They will present the latest evidence for the efficacy of specialized diets and promising emerging pharmacologic agents that may soon alter the course of these diseases for many patients. As a bonus feature, attendees will have the opportunity to interact with faculty on a 1:1 basis to address case-based questions in virtual breakout rooms post-symposium. In order to attend this MedscapeLIVE! virtual CME symposium you will also need to complete your registration for DDW Virtual 2021. *Complimentary registration is available for Industry Symposia.


Back Stage Pass Logo




Enhance Your Virtual Experience With Backstage Pass!

Join our 30-minute post-symposium breakout session connecting the program speakers and audience in the virtual environment. Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.

*Video Encouraged*




This activity is intended for gastroenterologists, allergists/clinical immunologists, and primary care providers, and other healthcare providers (HCPs) involved in the diagnosis and management of patients with EGIDs.


The goal of this activity is to improve understanding of disease pathology and novel treatment targets, as well as key diagnostic criteria needed to optimize earlier diagnosis.


Upon completion of this activity, participants will: Have increased knowledge regarding the [list][item]Clinical data on emerging treatments for EGIDs [/list] Have greater competence related to [list][item]Selecting treatments for patients with EGIDs [item]Employing evidence-based diagnostic criteria for EGIDs[/list] Demonstrate greater confidence in their ability to [list][item]Incorporate new and emerging treatments for EGIDs into practice[/list]


In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.25 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is not affiliated with Digestive Disease Week®.